Research Program Portfolio

HomeProfessionalsResearchResearch Program Portfolio ▶ 2017 ATS Foundation Partner Grants
2017 ATS Foundation Partner Grants

PLEASE NOTE:  We are no longer accepting applications for Partner Grants this cycle.

Anticipated Timeline

April 2017 Letter of Intent Period Opens
June 13, 2017 Deadline for Letter of Intent
August 2017 Invitation from scientific Advisory Committee for Full Applications
September 19, 2017 Full Application Deadline due by 11:59pm Eastern Time
November 2017 Grantee Notification
December 2017 Grant Start Date

Current Partner Grant Opportunities

alpha1
ATS Foundation/Alpha-1 Foundation Research Grant
1 grant available
$40,000 per year for 2 years
Target Audience:
Investigators interested in research that is relevant to alpha-1 antitrypsin deficiency (Alpha-1)
The focus of this research grant is proposals that have a high likelihood to advance the understanding of Alpha-1. Applications are encouraged from faculty members at any stage of their academic career. Applicants may request up to $40,000 per year for two years for salaries, supplies or a combination of these two. Indirect costs will not be paid to the sponsoring institution.
Award-specific eligibility:
• Junior investigators (as defined here) or established investigators at any stage in their career
• Appliants must not be current awardees of the Alpha-1 Foundation Research Program
• Must meet eligibility requirements for all grants found here
 Co-funded by the ATS Foundation and the Alpha-1 Foundation. Please visit alpha1.org for more information about our partner.
 
alamp
ATS Foundation/American Lung Association of the Mountain Pacific Research Grant
1 grant available
$50,000 per year for 2 years
Target Audience:
Investigators working at Oregon-based institutions interested in research relevant to lung disease, sleep, and critical care

The focus of this research grant is basic science and patient-oriented research investigating lung disease, sleep, and critical care. Patient-oriented research is defined as research performed with human subjects (or on material of human origin such as tissues or other specimen). This area of research includes 1) disease mechanism; 2) therapeutic interventions; 3) clinical trials; and 4) the development of new technologies. Applicants may request up to $50,000/year for 2 years for salaries, supplies or a combination of these two. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility:
• Junior investigators (as defined here)
• Investigators must be based in Oregon
• Must meet eligibility requirements for all grants found here

Fully funded by the American Lung Association of the Mountain Pacific. Please visit lung.org/associations/charters/mountain-pacific/ for more information about our partner.

 
hps
ATS Foundation/Hermansky-Pudlak Syndrome Network Research Grant
1 grant available
$40,000 per year for 2 years
Target Audience:
Investigators interested in research that is relevant to lung disease that results from Hermansky-Pudlak Syndrome
The focus of this research grant is proposals that have a high likelihood to advance the understanding of Hermansky-Pudlak Syndrome-associated lung disease. Applicants may request up to $40,000/year for 2 years for salaries, supplies or a combination of these two. Indirect costs will not be paid to the sponsoring institution.
Award-specific eligibility:
• Junior investigators (as defined here)
• Must meet eligibility requirements for all grants found here
Co-funded by the ATS Foundation and the Hermansky-Pudlak Syndrome Network.  Please visit hpsnetwork.org for more information about our partner.
 
hps
ATS Foundation/Mallinckrodt Pharmaceuticals Inc. Research Fellowship in Sarcoidosis
*Please note there was no letter of intent stage for this award; Full application deadline is Sept. 19th 

1 grant available
$40,000 per year for 2 years
Target Audience:
Investigators interested in research that is relevant to sarcoidosis
The focus of this research grant is proposals that advance research in the area of sarcoidosis. Applicants may request up to $40,000 per year for two years. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or for subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution. 
Award-specific eligibility:
• Junior investigators (as defined here)
• Must meet eligibility requirements for all grants found here
Fully funded by Mallinckrodt Pharmaceuticals Inc.  Please visit mallinckrodt.com for more information about our partner.
 
pcd
ATS Foundation/Primary Ciliary Dyskinesia (PCD) Foundation Research Grant
1 grant available
$40,000 per year for 2 years
Target Audience:
Investigators interested in advancing the understanding of primary ciliary dyskinesia (PCD)
The focus of this research grant is proposals that advance the understanding of primary ciliary dyskinesia (PCD), either through relevant basic/translational science or outstanding clinical science research projects. Applications are encouraged from faculty members at any stage of their academic career. Applicants may request up to $40,000/year for two years for salaries, supplies or a combination of these two. Indirect costs will not be paid to the sponsoring institution.
Award-specific eligibility:
• Junior investigators (as defined here) or established investigators at any stage in their career
• Must meet eligibility requirements for all grants found here
 Co-funded by the ATS Foundation and the PCD Foundation. Please visit pcdfoundation.org for more information about our partner.
 
pha
ATS Foundation/Pulmonary Hypertension Association Research Fellowship 
1 grant available
$40,000 per year for 2 years
Target Audience:
Investigators interested in research in pulmonary arterial hypertension
The focus of this research grant is to support research into the pathophysiology of PAH, toward elucidating mechanistic pathways and identifying novel therapeutic targets or biomarkers in adult or pediatric pulmonary hypertension. The project should have potential applicability to human pulmonary vascular diseases. Investigators are also encouraged to connect through PHA's professional network, PH Clinicians and Researchers, during the course of their research. Applicants may request up to $40,000/year for 2 years for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution.
Award-specific eligibility:
• Junior investigators (as defined here)
• Must meet eligibility requirements for all grants found here
Co-funded by the ATS Foundation and the Pulmonary Hypertension Association (PHA). Please visit phaassociation.org  for more information about our partner.
 
ResMed
ATS Foundation/ResMed Research Fellowship in Noninvasive Ventilation in COPD
1 grant available
$50,000 per year for 2 years
Target Audience:
Investigators interested in research relevant to noninvasive ventilation in COPD
The focus of this research grant is proposals that advance research in the area of noninvasive ventalition in COPD. Applicants may request up to $50,000 per year for two years. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or for subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution.
Award-specific eligibility:
• Junior investigators (as defined here)
• Must meet eligibility requirements for all grants found here
Fully funded by ResMed. Please visit resmed.com for more information about our partner.
 
ATSRP
ATS Foundation Tobacco-Dependence Research Fund Grant: For Research on Tobacco Dependence Mechanisms, Interventions, and Treatment
1 grant available
$50,000 per year for 2 years
Target audience:
Investigators interested in research on basic science and socio-behavioral mechanisms involved in tobacco dependence, smoking prevention, and tobacco cessation treatment. This grant is NOT intended to support studies that examine the adverse consequences of cigarette smoking.
The focus of this research grant is research with the potential to lead fewer people to start smoking, or to lead more people to cease smoking. Such research includes: 1.) basic mechanisms involved in tobacco dependence, including in such areas as neurogenetics, genetic epidemiology, pharmacology, neuropharmacology, cell receptors, airway sensory responses, and other areas that enhance understanding of the basic mechanisms causing tobacco dependence; 2.) investigation into the socio-behavioral factors, and ethnic or gender differences in tobacco dependency; 3.) screening methods for assessing dependency; and 4.) evidence-based guidelines for practitioners to integrate smoking cessation treatment into management of the patient’s respiratory condition. This grant is NOT intended to support studies that examine the adverse consequences of cigarette smoking. Trans-disciplinary, cross-department collaboration is encouraged. Applicants may request up to $50,000/year for 2 years for salaries, supplies or a combination of these two. Indirect costs will not be paid to the sponsoring institution.
Award-specific eligibility:
• Junior investigators (as defined here) or established investigators at any stage in their career 
• Must not examine the adverse consequences of cigarette smoking
• Must meet eligibility requirements for all grants found here
Fully funded by a grant from the ATS Foundation Tobacco-Dependence Research Fund
 

REVIEW PROCESS

Please note that after you submit your application it will be reviewed by Research Program staff. If there are any problems or if these guidelines have not been followed, your proposal will be un-submitted. Please makes sure that you check your email after you submit your application so that any outstanding issues may be addressed as quickly as possible.

The ATS Scientific Advisory Committee (SAC) will review the applications in November 2017. The membership of the SAC is listed on the ATS Website and additional ad hoc reviewers will be invited to participate as needed. Funding decisions will be made on the basis of scientific merit, novelty, and responsiveness to the purpose of the specific grant program.


ATS POLICY ON ADDITIONAL GRANT FUNDING

Simultaneous submission of grants with scientific overlap is allowed, but if multiple applications are funded, then the applicant must notify the Research Program within one month of formal notification of award. A subcommittee of the SAC will assess degree of overlap. In case of significant scientific overlap the applicant will have to choose between the ATS Foundation research grant and the other grant. Budgetary overlap is not allowed.


If your question is not answered in the FAQ, contact the ATS Foundation Research Program at researchprogram@thoracic.org.

 

Last Reviewed: October 2017